# FDA Inspection 1246254 - OSRX Inc. - October 25, 2024

Source: https://www.keypedia.com/records/fda_inspections/osrx-inc/24439e7d-2ec3-4f81-850d-a1beff32194e
Source feed: FDA_Inspections

> FDA Inspection 1246254 for OSRX Inc. on October 25, 2024. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1246254
- Company Name: OSRX Inc.
- Inspection Date: 2024-10-25
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Seattle District Office

## Related Documents

- [FDA Inspection 1283268 - 2025-11-14](https://www.keypedia.com/records/fda_inspections/osrx-inc/d2021fd6-4cc1-44ea-a35b-57a6016a0abe)
- [FDA Inspection 1154392 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/osrx-inc/469752ac-36c3-4f90-99a4-aff474f82d36)
- [FDA Inspection 1087576 - 2019-04-25](https://www.keypedia.com/records/fda_inspections/osrx-inc/dd0491e1-78cc-4e97-8abb-8c123ea117df)

Company: https://www.keypedia.com/companies/osrx-inc/aead9fd9-6208-40fd-bc2a-d477072c53ae

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913